Alternative Legal Service Providers use technology and innovative solutions to improve business efficiency.
Patent invalidation in India is possible by initiating pre-grant patent opposition or post-grant patent opposition.
Indian Patent Office has published a notice on June 19, 2020 stating that all deadlines stand suspended.
Patent registration process in India for software and mobile applications is visible from review of granted patents.
Refusal of software patent by Indian Patent Office for a patent filed by Google claiming wearable device.
Corporate and Commercial Laws Foreign investments in India for setting up new businesses are increasing every year and apt legal consultation is required for incorporating new business entity in India. Once incorporated, with a view to ensure strict corporate compliance, various legal services are required in the form of legal consultations, corporate secretarial services, regulatory… Continue reading Corporate Law Practice in India
Patent due diligence refers to an audit to assess patents owned by, or licensed to, a company, business or individual.
Amendment to Drug Trials Rules In recent years, India has made a name for itself in the international pharmaceutical arena as a preferred destination for leading global companies to conduct clinical trials and there exists a basic regulatory regime governing the conduct of clinical trials. In due course of time, adequate knowledge of good clinical… Continue reading Ethical & Regulatory Issues in Conducting Clinical Trials in India
Recently, we were contacted by Christine, who works with medicalbillingandcoding.org, and she informed us about recently published article, “15 TED Talks on the Future of Medicine”, which she thought clicks with tone of our site and the passions of our readers. So, the article has been reproduced hereinbelow: TED.com exists as one of the Internet’s… Continue reading 15 TED Talks on the Future of Medicine
Earlier this year, in Feb. 2012, FDA issued draft guidance on biosimilar product development, and The Patient Protection and Affordable Care Act, which was signed into law by President Obama on March 23, 2010, amended the Public Health Service Act to create an abbreviated approval pathway -- under section 351(k) -- for biological products that… Continue reading Patent Expirations & Biosimilar Drug Regulations In Pharmaceutical Industry: Regulatory Guidelines in India